Illumina’s Push to Democratize Genomics with the iSeq 100

Illumina, the San Diego-based leader in next-gen sequencing (NGS) instrumentation, usually makes a point of releasing its biggest product and business news at the JP Morgan Healthcare Conference, the annual scrum of biotech CEOs, VCs, and investors in San Francisco. Past years have included pronouncements regarding the fabled “$1,000 genome” and the spin out of GRAIL, the lavishly funded liquid biopsy company.This year, the big news came in a small package—one cubic foot to be